1 Department of Radiotherapy, Oncology Hospital, Hassan II University Hospital, Fez, Morocco.
2 Faculty of Medicine and Pharmacy, Sidi Mohammed Ben-Abdellah University, Fez, Morocco.
World Journal of Advanced Research and Reviews, 2026, 30(01), 235-240
Article DOI: 10.30574/wjarr.2026.30.1.0802
Received on 23 February 2026; revised on 28 March 2026; accepted on 31 March 2026
Juvenile nasopharyngeal angiofibroma (JNA) is a rare, highly vascular benign tumor characterized by locally aggressive behavior. While surgery remains the standard treatment, management of recurrent or advanced disease with skull base extension remains challenging.
We report the case of a 15-year-old male presenting with recurrent JNA initially treated surgically. The patient subsequently developed recurrence managed with embolization followed by incomplete resection. Further imaging demonstrated locoregional progression with skull base and intracranial extension. Given the extent of disease and limited surgical options, definitive radiotherapy was delivered to a total dose of 50 Gy. Treatment was well tolerated, with no significant acute or late toxicity. At follow-up, the patient showed complete clinical response and progressive radiological regression with no evidence of disease progression.
Radiotherapy represents an effective and well-tolerated treatment option for recurrent or unresectable JNA, particularly in advanced stages when surgical management is not feasible.
Juvenile Nasopharyngeal Angiofibroma; Radiotherapy; Recurrent Disease; Skull Base Extension; Embolization; Intracranial Extension
Preview Article PDF
Nisrine El Hayel, Kaoutar Soussy, Wissal Hassani, Samia Khalfi, Fatima Zahra Farhane, Zenab Alami and Touria Bouhafa. Radiotherapy in advanced recurrent juvenile nasopharyngeal angiofibroma: A case report. World Journal of Advanced Research and Reviews, 2026, 30(01), 235-240. Article DOI: https://doi.org/10.30574/wjarr.2026.30.1.0802.